More about

Anaphylaxis

News
January 26, 2024
1 min read
Save

Top in allergy/asthma: Anaphylaxis at work; some kids avoid peanuts despite negative test

Top in allergy/asthma: Anaphylaxis at work; some kids avoid peanuts despite negative test

Insect venom was the cause of 82.7% of cases of occupational anaphylaxis, followed by food, drugs and latex, according to a study published in Allergy.

News
January 17, 2024
3 min read
Save

Insect venom causes most occupational anaphylaxis

Insect venom causes most occupational anaphylaxis

Insect venom was the cause of most cases of occupational anaphylaxis, followed by food, drugs and latex, according to a study published in Allergy.

News
January 16, 2024
2 min read
Save

Hospital type, region significant predictors for observation time following anaphylaxis

Hospital type, region significant predictors for observation time following anaphylaxis

Most EDs do not have specific guidelines for observation time following anaphylaxis, and the average duration depends largely on comorbidities and the type of hospital, according to a survey study.

News
January 09, 2024
5 min read
Save

Q&A: Epinephrine nasal spray may overcome autoinjector limitations

Q&A: Epinephrine nasal spray may overcome autoinjector limitations

An intranasal epinephrine spray produced pharmacokinetic and pharmacodynamic results that were comparable or superior to intramuscular injections, according to a study published in The Journal of Allergy and Clinical Immunology: Global.

News
December 29, 2023
1 min read
Save

Top in allergy/asthma: Food allergy treatment; new practice parameters

Top in allergy/asthma: Food allergy treatment; new practice parameters

The FDA has granted priority review to omalizumab as a treatment for food allergy after accidental exposure, according to a press release.

News
December 22, 2023
4 min read
Save

Nasal epinephrine spray outcomes comparable with autoinjector, manual injections

Nasal epinephrine spray outcomes comparable with autoinjector, manual injections

An intranasal epinephrine spray produced pharmacokinetic and pharmacodynamic results that were comparable or superior to intramuscular injections, according to a study published in The Journal of Allergy and Clinical Immunology: Global.

News
December 20, 2023
2 min read
Save

FDA grants priority review to omalizumab in treatment of food allergy

FDA grants priority review to omalizumab in treatment of food allergy

The FDA has accepted a supplemental biologics application for the use of omalizumab to reduce allergic reactions due to accidental exposure in patients aged 1 year and older with at least one food allergy, according to a press release.

News
December 19, 2023
2 min watch
Save

VIDEO: FDA-requested study of epinephrine nasal spray underway

VIDEO: FDA-requested study of epinephrine nasal spray underway

ANAHEIM, Calif. — ARS Pharma is conducting an additional clinical trial of its neffy epinephrine nasal spray per FDA request, company cofounder, president and CEO Richard Lowenthal, MS, MSEL, told Healio.

News
December 19, 2023
4 min read
Save

Joint task force releases anaphylaxis, atopic dermatitis treatment parameters

Joint task force releases anaphylaxis, atopic dermatitis treatment parameters

Two new practice parameters from a joint task force published in Annals of Allergy, Asthma & Immunology provide evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis.

News
December 11, 2023
4 min read
Save

Customer discovery reveals why patients do not carry their epinephrine autoinjectors

Customer discovery reveals why patients do not carry their epinephrine autoinjectors

ANAHEIM, Calif. — Inconvenience and forgetfulness are among the reasons why people do not always carry their epinephrine autoinjectors, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

View more